Structure Therapeutics, Inc. (GPCR)
25.54
-0.13
(-0.51%)
USD |
NASDAQ |
Oct 09, 16:00
25.60
+0.06
(+0.23%)
After-Hours: 20:00
Structure Therapeutics Cash and Short Term Investments (Quarterly) : 1.343B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.343B |
| March 31, 2026 | 1.459B |
| December 31, 2025 | 1.446B |
| September 30, 2025 | 799.04M |
| June 30, 2025 | 786.51M |
| March 31, 2025 | 836.89M |
| December 31, 2024 | 883.52M |
| September 30, 2024 | 915.29M |
| June 30, 2024 | 927.14M |
| March 31, 2024 | 436.44M |
| Date | Value |
|---|---|
| December 31, 2023 | 467.32M |
| September 30, 2023 | 205.42M |
| June 30, 2023 | 224.58M |
| March 31, 2023 | 240.86M |
| December 31, 2022 | 90.84M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 107.30M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.95B |
| Novo Nordisk A/S | 6.880B |
| Pfizer Inc. | 11.70B |
| Viking Therapeutics, Inc. | 501.66M |
| Liquidia Corp. | 284.18M |